Back to top

Sell Rating Reaffirmed on Limited Earnings Visibility and Competitive Pressures; €32 Price Target Maintained

In a report released today, Anna Ractliffe from Bank of America Securities maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA, with a...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Fresenius Medical Care AG & Co. KGaA (FMS)